Werner Stüber

Title: Werner Stüber: Innovator in Erythropoietin Research

Introduction

Werner Stüber is a notable inventor based in Lahntal, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of erythropoietin (EPO) peptides and antibodies. His work has implications for both therapeutic and diagnostic applications.

Latest Patents

Stüber holds a patent for "Erythropoietin (EPO) peptides and antibodies directed against these." This patent describes the use of EPO peptides for preparing epitope-specific anti-EPO antibodies. The invention includes polyclonal and monoclonal antibodies that are effective for purifying EPO, EPO derivatives, or EPO peptides. Additionally, the anti-EPO antibodies can be utilized for the detection of EPO, particularly in an epitope-specific manner. The patent also covers anti-idiotype antibodies that mimic a receptor region of EPO, as well as pharmaceuticals containing EPO peptides and diagnostic aids for detecting EPO or anti-EPO antibodies.

Career Highlights

Werner Stüber has been associated with Dade Behring Marburg GmbH, where he has contributed to advancements in medical diagnostics and therapeutics. His innovative work in the field of EPO research has positioned him as a key figure in biopharmaceutical development.

Collaborations

Stüber has collaborated with Mathias Fibi, enhancing the research and development efforts in their field. Their partnership has likely contributed to the successful outcomes of their projects.

Conclusion

Werner Stüber's contributions to erythropoietin research exemplify the impact of innovation in biochemistry. His patent on EPO peptides and antibodies showcases the potential for advancements in medical diagnostics and therapeutics.